Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
June 30, 2014
Primary Completion Date
July 31, 2014
Conditions
Healthy Men and Women
Interventions
DRUG
Flupentixol/melitracen film-coated tablet
DRUG
Flupentixol/melitracen coated tablet (Deanxit®)
Trial Locations (1)
LS2 9LH
Covance Clinical Research Unit, Leeds
All Listed Sponsors
lead
H. Lundbeck A/S
INDUSTRY
NCT02179931 - Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®) | Biotech Hunter | Biotech Hunter